Sequenom Inc.

406 articles about Sequenom Inc.

• Sequenom Inc. Reports 2014 Final And Fourth Quarter Financials

  3/5/2015

• Cypher Genomics And Sequenom Inc. Announce Development Agreement

  1/22/2015

• Sequenom Inc. Announces Participation At The 33rd Annual J.P. Morgan Healthcare Conference

  1/6/2015

• Illumina And Sequenom Inc. Pool Noninvasive Prenatal Testing Intellectual Property And End Outstanding Patent Disputes

  12/3/2014

• Sequenom Inc. Announces Participation At The 26th Annual Piper Jaffray Healthcare Conference

  11/25/2014

• Sequenom Inc. Reports Financial Results For The Third Quarter Of 2014

  11/5/2014

• Sequenom Inc. Announces Date Of Third Quarter 2014 Financial Results And Conference Call

  10/21/2014

• Sequenom Inc. Pays $14.55 Million For Prenatal Testing Assets From Isis Innovation

  10/7/2014

• Sequenom Inc. Laboratories Presents New Data Supporting The Accuracy Of The MaterniT21® Plus Laboratory Developed Test In Clinical Setting

  9/22/2014

• Edico Genome Collaborates With Sequenom Inc. To Accelerate Analysis Of Whole Genome Data For Non-Invasive Prenatal Testing

  9/3/2014

• Sequenom Inc. Announces Participation At The 2014 Morgan Stanley Global Healthcare Conference

  9/2/2014

• Sequenom Inc. Announces Participation At The 2014 Wedbush Securities Life Sciences Management Access Conference

  8/5/2014

• Sequenom Inc. Reports Financial Results For The Second Quarter Of 2014

  7/30/2014

• Sequenom Inc. Enters Into License Agreement With Mayo Medical Laboratories

  7/30/2014

• Sequenom Inc. Announces Closing Of Initial Public Offering

  7/30/2014

• Sequenom Inc. Laboratories Presents New Data On The Enhanced Sequencing Series For The MaterniT21™ Plus Laboratory-Developed Test At 18th International Conference On Prenatal Diagnosis And Therapy

  7/22/2014

• Sequenom Inc. Laboratories Expands International Noninvasive Prenatal Testing Services To Broader Population With VisibiliT™ Test

  7/21/2014

• Sequenom Inc. Announces Date Of Second Quarter 2014 Financial Results And Conference Call

  7/15/2014

• NicOx SA And Sequenom Inc. Announce The Launch Of Expanded Access To Retnagene™ Test Portfolio In The U.S.

  6/19/2014

• NicOx SA And Sequenom Inc. Announce The Launch Of Expanded Access To Retnagene™ Test Portfolio In The U.S.

  6/19/2014